Study Protocol
Published on 25 Feb 2025
Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial
in Cancer Immunity and Immunotherapy